story of the week
Valoctocogene Roxaparvovec Therapy for Hemophilia A
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The New England Journal of Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Two-Year Outcomes of Valoctocogene Roxaparvovec Therapy for Hemophilia A
N. Engl. J. Med 2023 Feb 23;388(8)694-705, J Mahlangu, R Kaczmarek, A von Drygalski, S Shapiro, SC Chou, MC Ozelo, G Kenet, F Peyvandi, M Wang, B Madan, NS Key, M Laffan, AL Dunn, J Mason, DV Quon, E Symington, AD Leavitt, J Oldenburg, H Chambost, MT Reding, K Jayaram, H Yu, R Mahajan, KM Chavele, DB Reddy, J Henshaw, TM Robinson, WY Wong, SW PipeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.